{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:27:32Z","timestamp":1781173652704,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012752","name":"Elanco","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>While generally harmless to dogs, the cestode species <jats:italic>Echinococcus granulosus<\/jats:italic> and <jats:italic>Echinococcus multilocularis<\/jats:italic> have significant zoonotic importance, causing cystic echinococcosis and alveolar echinococcosis in humans, respectively. Regular deworming is essential to treat intestinal cestode infections in dogs and to reduce environmental egg contamination and thus the subsequent zoonotic risk of infection to intermediate hosts and humans. The studies described here evaluated the efficacy of a new novel chewable tablet combination containing lotilaner, moxidectin, praziquantel and pyrantel (Credelio Quattro, Elanco Animal Health) against <jats:italic>E. granulosus<\/jats:italic> and <jats:italic>E. multilocularis<\/jats:italic> infections in dogs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Four negative-controlled, masked, randomized laboratory studies were conducted. Two studies each evaluated the efficacy of Credelio Quattro at the minimum dosages of 20.0\u00a0mg\/kg lotilaner, 0.02\u00a0mg\/kg moxidectin, 5.0\u00a0mg\/kg praziquantel and 5.0\u00a0mg\/kg pyrantel against <jats:italic>E. granulosus<\/jats:italic> (Studies 1 and 2) and <jats:italic>E. multilocularis<\/jats:italic> (Studies 3 and 4). Studies 2 and 4 also included treatment groups that received praziquantel alone or lotilaner alone, at the same minimum dosages, to assess whether lotilaner, moxidectin or pyrantel interfered with the activity of praziquantel in Credelio Quattro against these two cestode species. In Studies 1 and 3, 16 purpose-bred dogs were divided into two groups of eight, while in Studies 2 and 4, 32 dogs were divided into four groups of eight. Dogs were experimentally inoculated with protoscolices on Day \u2013 28 for <jats:italic>E. granulosus<\/jats:italic> studies and on Day \u2013 18 or \u2013 20 for <jats:italic>E. multilocularis<\/jats:italic> studies. Credelio Quattro, placebo, praziquantel, or lotilaner tablets were administered orally at the lower half of the dosage range on Day 0. Efficacy was calculated based on the number of worms recovered at necropsy, 4 or 5 days post-treatment, in the treated group compared to the control.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Credelio Quattro was well tolerated in all dogs. Based on geometric mean worm counts, Credelio Quattro was 100% effective against both <jats:italic>E. granulosus<\/jats:italic> and <jats:italic>E. multilocularis.<\/jats:italic>\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Credelio Quattro administered once orally at the minimum dosages of 20\u00a0mg\/kg of lotilaner, 0.02\u00a0mg\/kg of moxidectin, 5.0\u00a0mg\/kg of praziquantel and 5.0\u00a0mg\/kg of pyrantel was safe and effective for the treatment and control of adult <jats:italic>E. granulosus<\/jats:italic> and <jats:italic>E. multilocularis<\/jats:italic> in dogs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13071-025-06735-w","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T03:51:01Z","timestamp":1741665061000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of a novel chewable tablet (Credelio Quattro\u2122) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of Echinococcus multilocularis and E. granulosus infections in dogs"],"prefix":"10.1186","volume":"18","author":[{"given":"Samuel","family":"Charles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertraut","family":"Altreuther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinshuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Wiseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig R.","family":"Reinemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padraig","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"6735_CR1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3201\/eid1202.050499","volume":"12","author":"CM Budke","year":"2006","unstructured":"Budke CM, Deplazes P, Torgerson PR. Global socioeconomic impact of cystic echinococcosis. Emerg Infect Dis. 2006;12:296\u2013303. https:\/\/doi.org\/10.3201\/eid1202.050499.","journal-title":"Emerg Infect Dis"},{"key":"6735_CR2","doi-asserted-by":"publisher","first-page":"8859116","DOI":"10.1155\/2020\/8859116","volume":"2020","author":"AT Gessese","year":"2020","unstructured":"Gessese AT. Review on epidemiology and public health significance of hydatidosis. Vet Med Int. 2020;2020:8859116. https:\/\/doi.org\/10.1155\/2020\/8859116.","journal-title":"Vet Med Int"},{"key":"6735_CR3","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00436-015-4855-7","volume":"115","author":"D Cvejic","year":"2016","unstructured":"Cvejic D, Schneider C, Fourie J, de Vos C, Bonneau S, Bernachon N, et al. Efficacy of a single dose of milbemycin oxime\/praziquantel combination tablets, Milpro((R)), against adult Echinococcus multilocularis in dogs and both adult and immature E. multilocularis in young cats. Parasitol Res. 2016;115:1195\u2013202. https:\/\/doi.org\/10.1007\/s00436-015-4855-7.","journal-title":"Parasitol Res"},{"key":"6735_CR4","volume-title":"WHO\/OIE manual on echinococcosis in humans and animals: a public health problem of global concern","author":"J Eckert","year":"2001","unstructured":"Gemmell MA, Meslin FX, Pawlowski ZS. WHO\/OIE manual on echinococcosis in humans and animals: a public health problem of global concern [Internet]. 2001 Dec."},{"key":"6735_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00075-18","author":"H Wen","year":"2019","unstructured":"Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, et al. Echinococcosis: Advances in the 21st century. Clin Microbiol Rev. 2019;32(2). https:\/\/doi.org\/10.1128\/CMR.00075-18.","journal-title":"Clin Microbiol Rev"},{"key":"6735_CR6","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.cvsm.2009.06.005","volume":"39","author":"G Conboy","year":"2009","unstructured":"Conboy G. Cestodes of dogs and cats in North America. Vet Clin North Am Small Anim Pract. 2009;39:1075\u201390. https:\/\/doi.org\/10.1016\/j.cvsm.2009.06.005.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"6735_CR7","unstructured":"Echinococcosis https:\/\/www.woah.org\/en\/disease\/echinococcosis\/. Accessed 02 May 2024."},{"key":"6735_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.parint.2005.06.002","volume":"54","author":"J Wei","year":"2005","unstructured":"Wei J, Cheng F, Qun Q, Nurbek, Xu SD, Sun LF, et al. Epidemiological evaluations of the efficacy of slow-released praziquantel-medicated bars for dogs in the prevention and control of cystic echinococcosis in man and animals. Parasitol Int. 2005;54:231\u20136. https:\/\/doi.org\/10.1016\/j.parint.2005.06.002.","journal-title":"Parasitol Int"},{"key":"6735_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.ijpara.2021.10.003","volume":"51","author":"MW Lightowlers","year":"2021","unstructured":"Lightowlers MW, Gasser RB, Hemphill A, Romig T, Tamarozzi F, Deplazes P, et al. Advances in the treatment, diagnosis, control and scientific understanding of taeniid cestode parasite infections over the past 50 years. Int J Parasitol. 2021;51:1167\u201392. https:\/\/doi.org\/10.1016\/j.ijpara.2021.10.003.","journal-title":"Int J Parasitol"},{"key":"6735_CR10","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.3201\/eid2808.212514","volume":"28","author":"J Schmidberger","year":"2022","unstructured":"Schmidberger J, Uhlenbruck J, Schlingeloff P, Maksimov P, Conraths FJ, Mayer B, et al. Dog ownership and risk for alveolar echinococcosis. Germany Emerg Infect Dis. 2022;28:1597\u2013605. https:\/\/doi.org\/10.3201\/eid2808.212514.","journal-title":"Germany Emerg Infect Dis"},{"key":"6735_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/med.2610030204","author":"P Andrew","year":"1983","unstructured":"Andrew P, Seubert J. Praziquantel. Med Res Rev. 1983. https:\/\/doi.org\/10.1002\/med.2610030204.","journal-title":"Med Res Rev"},{"key":"6735_CR12","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/BF01945954","volume":"33","author":"J Seubert","year":"1977","unstructured":"Seubert J, Pohlke R, Loebich F. Synthesis and properties of Praziquantel, a novel broad spectrum anthelmintic with excellent activity against Schistosomes and Cestodes. Experientia. 1977;33:1036\u20137.","journal-title":"Experientia"},{"key":"6735_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0034-5288(18)33092-3","volume":"24","author":"H Thomas","year":"1978","unstructured":"Thomas H, G\u00f6nnert R. The efficacy of praziquantel against cestodes in cats, dogs, and sheep. Res Vet Sci. 1978;24:20\u20135.","journal-title":"Res Vet Sci"},{"key":"6735_CR14","unstructured":"European Medicines Agency. Guideline on good clinical practice. VICH Topic GL9. http:\/\/www.ema.europa.eu\/docs\/en%20GB\/document%20library\/Scientific%20guideline\/2009\/10\/WC. Assessed 6 May 2024."},{"key":"6735_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/s0304-4017(00)00443-x","volume":"96","author":"J Vercruysse","year":"2001","unstructured":"Vercruysse J, Holdsworth P, Letonja T, Barth D, Conder G, Hamamoto K, et al. International harmonisation of anthelmintic efficacy guidelines. Vet Parasitol. 2001;96:171\u201393. https:\/\/doi.org\/10.1016\/s0304-4017(00)00443-x.","journal-title":"Vet Parasitol"},{"key":"6735_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s0304-4017(01)00615-x","volume":"103","author":"J Vercruysse","year":"2002","unstructured":"Vercruysse J, Holdsworth P, Letonja T, Conder G, Hamamoto K, Okano K, et al. International harmonisation of anthelmintic efficacy guidelines (Part 2). Vet Parasitol. 2002;103:277\u201397. https:\/\/doi.org\/10.1016\/s0304-4017(01)00615-x.","journal-title":"Vet Parasitol"},{"key":"6735_CR17","doi-asserted-by":"publisher","first-page":"109815","DOI":"10.1016\/j.vetpar.2022.109815","volume":"312","author":"F Beugnet","year":"2022","unstructured":"Beugnet F, Taweethavonsawat P, Traversa D, Fourie J, McCall J, Tielemans E, et al. World Association for the Advancement of Veterinary Parasitology (WAAVP): second edition of guidelines for evaluating the efficacy of anthelmintics for dogs and cats. Vet Parasitol. 2022;312:109815. https:\/\/doi.org\/10.1016\/j.vetpar.2022.109815.","journal-title":"Vet Parasitol"},{"key":"6735_CR18","unstructured":"CAPC. Guidelines for controlling internal and external parasites in US dogs and cats. 2018. http:\/\/www.petsandparasites.org\/resources\/capc-guidelines. Accessed 08 Oct 2024."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06735-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-06735-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06735-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T15:29:52Z","timestamp":1741706992000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-06735-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6735"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-06735-w","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocols were reviewed and approved by the Animal Care and Use Committee of the institution performing the studies and by the Elanco Animal Health Animal Care and Use Committee prior to study conduct.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SC, GA, SW, XW and LY are employees of Elanco Animal Health.  CR, MU, DS and PD were contracted to participate in the studies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}